News

Doryx is a tetracycline-class antibacterial indicated for rickettsial infections, sexually transmitted infections, respiratory tract infections, specific bacterial infections, ophthalmic infections, anthrax, including inhalational anthrax (post-exposure), alternative treatment for

The total purchase price is $80m, consisting of a cash payment of $28.1m at closing, and a 7-year subordinated unsecured promissory note of $51.9m. The acquisition enables SPI

Belinostat (PXD 101) is a Class I and II HDAC inhibitor that is being studied in multiple clinical trials as a single agent or in combination with chemotherapeutic

SXC Health Solutions has agreed to pay $100m in cash, subject to a customary working capital adjustment, with an additional $5.5m subject to the achievement of certain performance

Under the terms of the funding agreement, which is in support of Compugen’s Pipeline Program, Baize Investments has obtained a financial interest in five designated Compugen-discovered molecules and

Phase II clinical trials of Multikine demonstrated the product was safe and well-tolerated and eliminated tumors in 12% of the subjects less than a month into treatment. CEL-SCI

In a filing to the Bombay Stock Exchange, Surya Pharmaceuticals said the transaction was financed through a mix of internal accruals and debt from EXIM Bank. With this

RPS offers clients a broad spectrum of outsourcing solutions ranging from globally embedded functional and cross-functional solutions to enhanced global full-service solutions. RPS CEO and chairman Daniel Perlman

Cumberland has informed the US Food and Drug Administration (FDA) of its plan to voluntarily recall these lots of Acetadote as a precautionary measure. According to the company,